BTIG analyst Ryan Zimmerman upgrades $Integra Lifesciences (IART.US)$ to a hold rating, and maintains the target price at $20.
According to TipRanks data, the analyst has a success rate of 43.8% and a total average return of 1.8% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Integra Lifesciences (IART.US)$'s main analysts recently are as follows:
Integra LifeSciences has faced persistent operational challenges over the past two years that have been difficult to surmount. A stabilization of the business is necessary to regain investor trust. The company is perceived to persist in establishing hopeful expectations that afford minimal margin for error. Concerns linger that Integra may have set its forecasts for Q4 and the year 2025 at levels that could be overly ambitious.
The valuation of Integra LifeSciences has reached a level where significant downside appears unlikely, according to an analyst. Near-term pressure on the shares might persist due to tax-loss selling as the year concludes, but the stock is beginning to attract the interest of deep value investors.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
